BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10667130)

  • 21. [Early response to oral cobalamin therapy in older patients with vitamin B12 deficiency].
    Kaltenbach G; Noblet-Dick M; Andrès E; Barnier-Figue G; Noel E; Vogel T; Perrin AE; Martin-Hunyadi C; Berthel M; Kuntzmann F
    Ann Med Interne (Paris); 2003 Mar; 154(2):91-5. PubMed ID: 12746645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adults.
    Teplitsky V; Huminer D; Zoldan J; Pitlik S; Shohat M; Mittelman M
    Isr Med Assoc J; 2003 Dec; 5(12):868-72. PubMed ID: 14689755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsecretory myeloma. A case report.
    Moehring HD
    Clin Orthop Relat Res; 1982; (171):196-201. PubMed ID: 7140070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement.
    Abyad A
    J Nutr Health Aging; 2002; 6(4):254-60. PubMed ID: 12486445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.
    Huerta JM; González S; Vigil E; Prada M; San Martín J; Fernández S; Patterson AM; Lasheras C
    Clin Biochem; 2004 Oct; 37(10):904-10. PubMed ID: 15369722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
    Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrelationships between Vitamin B12 and folic acid in myelomatosis: cobalamin coenzyme and tetrahydrofolic acid function.
    Hansen OP; Drivsholm A; Hippe E; Quadros E; Linnell JC
    Scand J Haematol; 1978 Apr; 20(4):360-70. PubMed ID: 418497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
    Urbańska-Ryś H; Robak T
    Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of thalidomide in the treatment of multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [IgM multiple myeloma. Case report and review of the literature [].
    Marín-López A; Landero de Ruiz N; Armenta Olvera T; Ruiz-Argüelles GJ
    Rev Invest Clin; 1982; 34(2):175-8. PubMed ID: 7123028
    [No Abstract]   [Full Text] [Related]  

  • 34. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
    Katodritou E; Verrou E; Hadjiaggelidou C; Gastari V; Laschos K; Kontovinis L; Kapetanos D; Constantinou N; Terpos E; Zervas K
    Am J Hematol; 2008 Sep; 83(9):697-701. PubMed ID: 18626886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment].
    Koiso H; Tahara K; Osaki Y; Mawatari M; Sekigami T; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
    Rinsho Ketsueki; 2009 Feb; 50(2):78-82. PubMed ID: 19265298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
    Schütt P; Ebeling P; Buttkereit U; Brandhorst D; Opalka B; Poser M; Müller S; Flasshove M; Moritz T; Seeber S; Nowrousian MR
    Ann Hematol; 2005 Sep; 84(9):594-600. PubMed ID: 15744524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term complete remission in IgD-myeloma.
    Bemelmans RH; van Toorn DW; van Leeuwen L; Schaar CG
    Eur J Haematol; 2006 Apr; 76(4):339-41. PubMed ID: 16519706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia].
    Takasaki Y; Moriuchi Y; Tsushima H; Ikeda E; Koura S; Taguchi J; Fukushima T; Tomonaga M; Ikeda S
    Rinsho Ketsueki; 2002 Mar; 43(3):165-9. PubMed ID: 11979747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.